MoneyWorks4Me

Lyka Labs informs about AGM and annual report

17 Jul 2026 Evaluate

Pursuant to Regulation 34(1) of the SEBI Listing Regulations, Lyka Labs has informed that it enclosed the Annual Report of the Company along with the Notice of the AGM and other Statutory Reports for the Financial Year 2025-26 which is being sent through electronic mode to those Members whose e-mail addresses are registered with the Company / Registrar and Transfer Agent / Depository Participants. Further, in accordance with Regulation 36(1)(b) of the SEBI Listing Regulations, the Company will send a letter to the Shareholders whose e-mail addresses are not registered with the Company/RTA/DPs, providing a web-link from where the Annual Report can be accessed on the website of the Company. The same is also available on the website of the Company at https://www.lykalabs.com/Lyka%20Labs%20Annual%20Report%20%2025-26%20(1).pdf.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1851.00
Dr. Reddys Labs. 1199.60
Cipla 1398.30
Lupin 2093.70
Zydus Lifesciences 1181.00
View more..